Piramal Pharma Appoints Viral Gandhi as CTO

Piramal Pharma Ltd announced the appointment of Mr. Viral Gandhi as Chief Technology Officer (CTO) and Senior Management Personnel, effective October 1, 2026. The decision was approved by the Board of Directors based on the recommendation of the Nomination and Remuneration Committee. Mr. Gandhi brings over two and a half decades of experience in technology and digital strategy, having previously served as CIO at Cox & Kings Group and held significant roles at Tata Consultancy Services (TCS). He has a proven track record in driving digital transformation and implementing innovative technology solutions across various global organizations. His expertise includes building technology culture and propelling business growth through digital platforms. Mr. Gandhi holds an Executive Leadership Program from Harvard Business School and a Strategy and Innovation Program from MIT, along with an Engineering degree from VJTI, Mumbai.